BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14635602)

  • 1. [Survival at 5 years of adult patients with acute lymphoblastic leukemia].
    Durán-Nah J; Dávila-Velázquez J; Cetina-Ortiz M
    Rev Invest Clin; 2003; 55(4):394-9. PubMed ID: 14635602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of adult acute lymphoblastic leukemia: a single center experience.
    Usman M; Burney I; Nasim A; Adil SN; Salam A; Siddiqui T; Khurshid M
    J Pak Med Assoc; 2003 Sep; 53(9):384-8. PubMed ID: 14620310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia in adults. Comparative study of clinicobiologic characteristics and of response to treatment in terms of age in a group of 41 patients].
    Ribera JM; Granada I; Navarro JT; Vela D; Juncá J; Flores A; Millá F; Feliu E
    Med Clin (Barc); 1996 Oct; 107(11):401-4. PubMed ID: 9045000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
    Le QH; Thomas X; Ecochard R; Iwaz J; Lhéritier V; Michallet M; Fiere D
    Cancer; 2007 May; 109(10):2058-67. PubMed ID: 17407135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients].
    Jin FY; Zou DH; Wang GR; Xu Y; Feng SZ; Zhao YZ; Han MZ; Yan WW; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):645-8. PubMed ID: 16620547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemia in patients sixty years of age and older: a twenty year single institution review.
    Leger CS; Leitch HA; Galbraith PF; Li CH; Vickars LM
    Am J Clin Oncol; 2009 Apr; 32(2):137-41. PubMed ID: 19307947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia.
    Karimi M; Yarmohammadi H; Sabri MR
    Med Sci Monit; 2002 Dec; 8(12):CR792-6. PubMed ID: 12503037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
    Huguet F; Leguay T; Raffoux E; Thomas X; Beldjord K; Delabesse E; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Lafage-Pochitaloff M; Chassevent A; Lhéritier V; Macintyre E; Béné MC; Ifrah N; Dombret H
    J Clin Oncol; 2009 Feb; 27(6):911-8. PubMed ID: 19124805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.
    Thakkar SG; Fu AZ; Sweetenham JW; Mciver ZA; Mohan SR; Ramsingh G; Advani AS; Sobecks R; Rybicki L; Kalaycio M; Sekeres MA
    Cancer; 2008 May; 112(10):2233-40. PubMed ID: 18348307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate and prognostic factors in patients with intestinal failure.
    Vantini I; Benini L; Bonfante F; Talamini G; Sembenini C; Chiarioni G; Maragnolli O; Benini F; Capra F
    Dig Liver Dis; 2004 Jan; 36(1):46-55. PubMed ID: 14971815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial.
    Huynh BC; Rovner A; Rich MW
    Arch Intern Med; 2006 Sep; 166(17):1892-8. PubMed ID: 17000947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcome in childhood ALL: experience from a tertiary care centre in North India.
    Kulkarni KP; Marwaha RK; Trehan A; Bansal D
    Pediatr Blood Cancer; 2009 Aug; 53(2):168-73. PubMed ID: 19405133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ;
    Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
    Dahlke J; Kröger N; Zabelina T; Ayuk F; Fehse N; Wolschke C; Waschke O; Schieder H; Renges H; Krüger W; Kruell A; Hinke A; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2006 Jan; 37(2):155-63. PubMed ID: 16284608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients.
    Hamaki T; Kami M; Kanda Y; Yuji K; Inamoto Y; Kishi Y; Nakai K; Nakayama I; Murashige N; Abe Y; Ueda Y; Hino M; Inoue T; Ago H; Hidaka M; Hayashi T; Yamane T; Uoshima N; Miyakoshi S; Taniguchi S
    Bone Marrow Transplant; 2005 Mar; 35(6):549-56. PubMed ID: 15756282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.